Wednesday morning, 15 companies reached new 52-week lows.

Interesting Facts:

• The largest company in terms of market cap to set a new 52-week low was Vistra VST.
• Agile Therapeutics AGRX was the smallest company by market cap to set a new 52-week low.
• Esperion Therapeutics ESPR made the largest move down on the session, with shares plummeting 25.71% to reach its 52-week low.

During the first half-hour of trading on Wednesday, the following stocks set new 52-week lows:

• Vistra VST shares hit a yearly low of $15.71. The stock was down 0.61% on the session.
• National Beverage FIZZ shares set a new yearly low of $45.49 this morning. The stock was up 0.2% on the session.
• Array Technologies ARRY shares fell to $25.20 on Wednesday, setting a new 52-week low with a shift of up 0.8%.
• Mercury Systems MRCY shares fell to $52.43 on Wednesday, setting a new 52-week low with a shift of down 23.46%.
• MorphoSys MOR shares set a new 52-week low of $21.26. The stock traded down 2.81%.
• Deciphera Pharmaceuticals DCPH shares hit a yearly low of $38.87. The stock was down 8.5% on the session.
• Atea Pharmaceuticals AVIR stock broke to a new 52-week low of $20.69 on Wednesday. Shares of the company traded up 5.0%.
• Arco Platform ARCE stock hit $23.79 on Wednesday morning, setting a new 52-week low for a change of down 1.51%.
• Olema Pharmaceuticals OLMA stock set a new 52-week low of $22.60 on Wednesday, moving down 1.29%.
• Esperion Therapeutics ESPR stock set a new 52-week low of $18.01 on Wednesday, moving down 25.71%.
• Inozyme Pharma INZY shares hit a yearly low of $16.52. The stock was up 1.1% on the session.
• SQZ Biotechnologies SQZ stock hit a yearly low of $11.35. The stock was down 3.19% for the day.
• Heritage Insurance Hldgs HRTG stock drifted down 3.09% on Wednesday morning to hit a new 52-week low of $8.62.
• Aptinyx APTX stock hit a yearly low of $2.45. The stock was down 0.4% for the day.
• Agile Therapeutics AGRX stock hit a new 52-week low of $1.52. The stock was down 8.75% on the session.

Be sure to stay with Benzinga for updates on further action in these stocks!